Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

iHIVARNA Consortium

Onderzoeksoutput: Bijdrage aan tijdschriftBrief

Uittreksel

Following publication of the original article [1], we have been notified that end note would need to be adjusted.

TaalEngels
TijdschriftTrials
Volume20
Exemplaarnummer1
Pagina's (van-tot)721
ISSN1745-6215
DOI's
StatusGepubliceerd - 2019

Vingerafdruk Bekijk de onderzoeksthema's van 'Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy'. Samen vormen ze een unieke vingerafdruk.

Dit citeren